Prognostic Relationship of Diseases of the Ischemic Heart Disease and Chronic Kidney Disease
Modern research increasingly confirms the close relationship between coronary heart disease (CHD) and chronic kidney disease (CKD), their combination is recognized as unfavorable, which leads to a deterioration in the prognosis and course of both conditions. The pathogenetic aspects and prognostic predictors of coronary heart disease and CKD have not yet been fully studied, which makes research in this area very relevant. The ultimate goal of such research is to reduce the burden of disease through early diagnosis, prediction, and prevention. This review article is aimed at analyzing the existing scientific literature data on the pathophysiological mechanisms linking these diseases. The authors study key mechanisms such as inflammation, oxidative stress, and endothelial dysfunction, which play an important role in the progression of coronary heart disease and CKD. The analysis of existing biomarkers that can help in the early diagnosis of CKD in patients with coronary heart disease is carried out. Glomerular filtration rate (GFR) and microalbuminuria test (MAU) are not early markers of kidney damage. Galectin-3 and plasma growth differentiation factor 15 (GDF-15) are markers of myocardial fibrosis, and a positive correlation has been found between their plasma levels and the incidence of CKD. New research is required aimed at further, deeper study of the relationship between coronary heart disease and CKD.
Ziuzina A.A., Vishnevskij V.I., Vishnevskij M.V. 2025. Prognostic Relationship of Diseases of the Ischemic Heart Disease and Chronic Kidney Disease. Challenges in Modern Medicine, 48(2): 125–133 (in Russian). DOI: 10.52575/2687-0940-2025-48-2-125-133. EDN: BSRREO
While nobody left any comments to this publication.
You can be first.
Alidzhanova Kh.G., Rzhevskaya O.N., Sagirov M.A., Gazaryan G.A. 2017. Prognosticheskoe znachenie khronicheskoy bolezni pochek u bol'nykh s ostrym koronarnym sindromom [Prognostic Value of Chronic Kidney Disease in Patients with Acute Coronary Syndrome]. Sklifosovsky Journal of Emergency Medical Care. 6(2): 132–139. doi: 10.23934/2223-9022-2017-6-2-132-139
Demchuk O.V., Sukmanova I.A. 2023. Prognozirovanie chastoty razvitiya hronicheskoj bolezni pochek u pacientov s infarktom miokarda i ostrym povrezhdeniem pochek [Predicting the Incidence of Chronic Kidney Disease in Patients with Myocardial Infarction and Acute Kidney Injury]. Russian Journal of Cardiology. 28(6): 5247. doi: 10.15829/1560-4071-2023-5247
Drapkina O.M., Deeva T.A. 2015. Galektin-3 – biomarker fibroza u pacientov s metabolicheskim sindromom [Galectin-3 – Biomarker of Fibrosis in Patients with Metabolic Syndrome. Russian Journal of Cardiology]. 9(125): 96–102. doi: 10.15829/1560-4071-2015-9-96-102
Klinicheskie rekomendacii Ministerstva zdravoohraneniya RF «Stabil'naya ishemicheskaya bolezn' serdca» [Clinical Recommendations of the Ministry of Health of the Russian Federation “Stable Coronary Heart Disease”]. 2024. Official Internet Portal of Legal Information. 155. doi: 10.15829/1560-4071-2024-6110
Klinicheskie rekomendacii Ministerstva zdravoohraneniya RF «Hronicheskaya bolezn' pochek» [Clinical Recommendations of the Ministry of Health of the Russian Federation “Chronic Kidney Disease”]. 2021. Official Internet Portal of Legal Information. 469.
Briasoulis A., Bakris G.L. 2013. Chronic Kidney Disease as a Coronary Artery Disease Risk Equivalent. Current Cardiology Reports. 15(3): 340. doi:10.1007/s11886-012-0340-4.
Cepoi M., Duca S.T., Chetran A., Costache A.D., Spiridon M.R., Afrasanie I., Leanca S.A., Dmour B., Matei I.T., Miftode R.S., Miftode L., Prepeliuc C.S., Haba M.S.C., Badescu M.C., Costache I.I. 2023. Chronic Kidney Disease Associated with Ischemic Heart Disease: To What Extent Do Biomarkers Help? Life (Basel). 14(1): 34. doi:10.3390/life14010034
Conversano С., Di Giuseppe M. 2021. Psychological Factors as Determinants of Chronic Conditions: Clinical and Psychodynamic Advances. Frontiers in Psychology. 12: 635708. doi:10.3389/fpsyg.2021.635708
Damman K., Testani J.M. 2015. The Kidney in Heart Failure: An Update. European Heart Journal. 36(23): 1437–1444. doi: 10.1093/eurheartj/ehv010
Jankowski J., Floege J., Fliser D., Bohm M., Marx N. 2021. Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options. Circulation. 143(11): 1157–1172. doi: 10.1161/CIRCULATIONAHA.120.050686
Kempf T., Eden M., Strelau J., Naguib M., Willenbockel C., Tongers J., Heineke J., Kotlarz D., Xu J., Molkentin J.D., Niessen H.W., Drexler H., Wollert K.C. 2006. The Transforming Growth Factor Superfamily Member Growth-Differentiation Factor-15 Protects the Heart from Ischemia/Reperfusion Injury. Circulation Research. 98(3): 351–60. doi:10.1161/01.RES.0000202805.73038.48
Kotwal S., Perkovic V. 2024. Kidney Disease as a Cardiovascular Disease Priority. Circulation. 150(13): 975–977. doi:10.1161/CIRCULATIONAHA.124.068242
Li X., Liang Q., Zhong J., Gan L., Zuo L. 2023. The Effect of Metabolic Syndrome and Its Individual Components on Renal Function: A Meta-Analysis. Journal of clinical medicine. 12(4): 1614. doi: 10.3390/jcm12041614
Lousa I., Reis F., Beirão I., Alves R., Belo L., Santos-Silva A. 2020. New Potential Biomarkers for Chronic Kidney Disease Management – A Review of the Literature. International Journal of Molecular Sciences. 22(1): 43. doi: 10.3390/ijms22010043
McCullough P.A., Amin A., Pantalone K.M., Ronco C. 2022. Cardiorenal Nexus: A Review With Focus on Combined Chronic Heart and Kidney Failure, and Insights From Recent Clinical Trials. Journal of the American Heart Association. 11(11): e024139. doi: 10.1161/JAHA.121.024139
Ogata H., Sugawara H., Yamamoto M., Ito H. 2024. Phosphate and Coronary Artery Disease in Patients with Chronic Kidney Disease. Journal of Atherosclerosis and Thrombosis. 31(1): 1–14. doi: 10.5551/jat.RV22012
Powell-Wiley T.M, Poirier P., Burke L.E., Despres J., Gordon-Larsen P., Lavie C.J., Lear S.A., Ndumele C.E, Neeland I.J., Sanders P., St-Onge M. American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Epidemiology and Prevention; and Stroke Council. 2021. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 143(21): e984-e1010. doi: 10.1161/CIR.0000000000000973
Schrauben S.J, Apple B.J., Chang A.R. 2022. Modifiable Lifestyle Behaviors and CKD Progression: A Narrative Review. Kidney 360. 3(4): 752–778. doi: 10.34067/KID.0003122021
Scurt F.G., Ganz M.J., Herzog C., Bose K., Mertens P.R., Chatzikyrkou C. 2023. Association of Metabolic Syndrome and Chronic Kidney Disease. Obesity Reviews. 25(1): e13649. doi: 10.1111/obr.13649
Su G., Song H., Lanka V., Liu X., Fang F., Valdimarsdottir U.A, Carrero J.J. 2021. Stress Related Disorders and the Risk of Kidney Disease. Kidney International Reports. 6(3): 706–715. doi: 10.1016/j.ekir.2020.12.032
Szlagor M., Dybiec J., Młynarska E., Rysz J., Franczyk B. 2023. Chronic Kidney Disease as a Comorbidity in Heart Failure. International journal of molecular sciences. 24(3): 2988. doi: 10.3390/ijms24032988
Wright R.S., Reeder G.S., Herzog C.A., Albright R.C., Williams B.A., Dvorak D.L., Miller W.L., Murphy J.G., Kopecky S.L., Affe A.S. 2002. Acute Myocardial Infarction and Renal Dysfunction: A High-Risk Combination. Ann. Intern. Med. 137(7): 563–570. doi: 10.7326/0003-4819-137-7-200210010-00007
Zoccali C., Mallamaci F., Halimi J-M., Rossignol P., Sarafidis P., De Caterina R., Giugliano R., Zannad F. 2024. From Cardiorenal Syndrome to Chronic Cardiovascular and Kidney Disorder. Clinical Journal of the American Society of Nephrology. 19(6): 813–820. doi:10.2215/CJN.0000000000000361
The work was performed at I.S. Turgenev OSU within the framework of state assignment No. 075-00195-25-00 for 2025 and for the planning period of 2026 and 2027, FSGN project-2024-0014 (1024041900023-6-3.1.3; 3.2.12; 3.2.4).